Relay Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RLAY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

209,848

Value ($000)

1,775

Weight

0.0%

2020 Q3 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,775	0.0%	209,848	12/31/2025
2025 Q3	11/14/2025	1,056	0.0%	202,244	9/30/2025
2025 Q2	8/14/2025	1,415	0.0%	408,902	6/30/2025
2025 Q1	5/19/2025	790	0.0%	301,550	3/31/2025
2024 Q4	2/14/2025	958	0.0%	232,582	12/31/2024
2024 Q3	11/14/2024	1,581	0.0%	223,289	9/30/2024
2024 Q2	8/14/2024	1,367	0.0%	209,649	6/30/2024
2024 Q1	5/15/2024	4,626	0.0%	557,296	3/31/2024
2023 Q4	2/14/2024	9,269	0.0%	841,866	12/31/2023
2023 Q3	11/13/2023	7,278	0.0%	865,455	9/30/2023
2023 Q2	8/11/2023	14,601	0.0%	886,542	6/30/2023
2023 Q1	5/15/2023	14,601	0.0%	886,542	3/31/2023
2022 Q4	2/14/2023	12,191	0.0%	815,998	12/31/2022
2022 Q3	11/14/2022	18,557	0.0%	829,560	9/30/2022
2022 Q2	8/12/2022	13,093	0.0%	781,643	6/30/2022
2022 Q1	5/16/2022	17,193	0.0%	574,447	3/31/2022
2021 Q4	2/14/2022	18,895	0.0%	615,258	12/31/2021
2021 Q3	11/15/2021	7,386	0.0%	234,246	9/30/2021
2021 Q2	8/16/2021	9,595	0.0%	262,241	6/30/2021
2021 Q1	5/14/2021	14,708	0.0%	425,451	3/31/2021
2020 Q4	3/1/2021	20,131	0.0%	484,395	12/31/2020
2020 Q3	11/13/2020	10,840	0.0%	254,509	9/30/2020